Depression in Japanese patients with chronic obstructive pulmonary disease: A cross-sectional study

Respiratory Care

Volumn 58, Issue 7, 2013, Pages 1196-1203

  Horita, Nobuyuki ^a   Kaneko, Takeshi ^b   Shinkai, Masaharu ^b   Yomota, Makiko ^c   Morita, Satoshi ^c   Mengr, Bruce K Rubin ^d   Ishigatsubo, Yoshiaki ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c Fraternity Memorial Hospital Tokyo   (Japan)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

COPD; Depression; Geriatric; Japan

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SALBUTAMOL; THEOPHYLLINE;

6 MIN WALK DISTANCE; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; GERIATRIC DEPRESSION SCALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCORE; OUTPATIENT; PHYSICAL PARAMETERS; PREDICTIVE VALUE; PREVALENCE; PULSE OXIMETRY; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SMOKING; SOCIAL ASPECT; SOCIAL STATUS; SPIROMETRY; SURVIVAL RATE;

COPD; DEPRESSION; GERIATRIC; JAPAN;

AGED; AGED, 80 AND OVER; BRIEF PSYCHIATRIC RATING SCALE; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DEPRESSION; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS DISPARITIES; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC;

EID: 84879365760     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02065     Document Type: Article

References (48)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
2. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003;114(9):758-762.
3. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167(1):60-67.
4. Dowson CA, Town GI, Frampton C, Mulder RT. Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res 2004;56(3):333-340.
5. Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD 2005;2(1):185-193.
6. Wilson I. Depression in the patient with COPD. Int J Chron Obstruct Pulmon Dis 2006;1(1):61-64.
7. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005;127(4):1205-1211.
8. Kessler R, Ståhl E, Vogelmeier C, Haughney J, Trudeau E, Löfdahl CG, Partridge MR. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest 2006;130(1):133-142.
9. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006;47(4):312-319.
10. Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999;60(Suppl 7):4-9; discussion 10-11.
11. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277(4):333-340.
12. Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, et al. Depression, anxiety and health status after hospitalization for COPD: a multicentre study in the Nordic countries. Respir Med 2006;100(1):87-93.
13. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006;100(10):1767-1774.
14. Hanania NA, Mullerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011;183(5):604-611.
15. Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001;21(2): 80-86.
16. van Manen JG, Bindels PJ, Dekker FW, IJzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002;57(5):412-416.
17. Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Rela- tionship to functional capacity. Chest 1985;87(1):35-38.
18. Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med 1998;92(10):1231-1236.
19. Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J 2005; 26(2):242-248.
20. Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study. Respir Res 2009;10:1.
21. Ng TP, Niti M, Fones C, Yap KB, Tan WC. Co-morbid association of depression and COPD: a population-based study. Respir Med 2009;103(6):895-901.
22. Omachi TA, Katz PP, Yelin EH, Gregorich SE, Iribarren C, Blanc PD, Eisner MD. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 2009;122(8): 778.e9-e15.
23. Mishima M, Oku Y, Muro S, Hirai T, Chin K, Ohi M, et al. Relationship between dyspnea in daily life and psycho-physiologic state in patients with chronic obstructive pulmonary disease during long- term domiciliary oxygen therapy. Intern Med 1996;35(6):453-458.
24. Borak J, Chodosowska E, Matuszewski A, Zielinski J. Emotional status does not alter exercise tolerance in patients with chronic ob- structive pulmonary disease. Eur Respir J 1998;12(2):370-373.
25. Chavannes NH, Huibers MJ, Schermer TR, Hendriks A, van Weel C, Wouters EF, et al. Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract 2005;22(6):604-607.
26. Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J 2008;32(1):53-60.
27. Bentsen SB, Henriksen AH, Wentzel-Larsen T, Hanestad BR, Wahl AK. What determines subjective health status in patients with chronic obstructive pulmonary disease: importance of symptoms in subjec- tive health status of COPD patients. Health Qual Life Outcomes 2008;6:115.
28. Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 2009;103(10):1572- 1579.
29. Borge CR, Wahl AK, Moum T. Association of breathlessness with multiple symptoms in chronic obstructive pulmonary disease. J Adv Nurs 2010;66(12):2688-2700.
30. Hynninen MJ, Pallesen S, Nordhus IH. Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis 2007;2(3):323-328.
31. Young CB, Fang DZ, Zisook S. Depression in Asian-American and Caucasian undergraduate students. J Affect Disord 2010;125(1-3): 379-382.
32. Jamil H, Grzybowski M, Hakim-Larson J, Fakhouri M, Sahutoglu J, Khoury R, et al. Factors associated with self-reported depression in Arab, Chaldean, and African Americans. Ethn Dis 2008;18(4):464-470.
33. Iguchi A, Senjyu H, Hayashi Y, Kanada R, Iwai S, Honda S, et al. Relationship between depression in patients with COPD and the percent predicted FEV1, BODE Index, and health-related quality of life. Respir Care 2013;58(2):334-339.
34. Ferraro FR, Chelminski I. Preliminary normative data on the Geriatric Depression Scale-Short Form (GDS-SF) in a young adult sample. J Clin Psychol 1996;52(4):443-447.
35. Giordano M, Tirelli P, Ciarambino T, Gambardella A, Ferrara N, Signoriello G, et al. Screening of depressive symptoms in young-old hemodialysis patients: relationship between Beck Depression Inventory and 15-item Geriatric Depression Scale. Nephron Clin Pract 2007;106(4):c187-c192.
36. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
37. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008;134(4 Suppl):43S-56S.
38. American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guide-lines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1):111-117.
39. Japanese Respiratory Society, Committee of Respiratory Physiology. Reference values of spirogram and arterial blood gas analysis for Japanese. Tokyo: Japanese Respiratory Society; 2001.
40. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155(4):1278-1282.
41. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999;54(8):688-692.
42. Calikoglu M, Şahin G, Yazici AE, Yazici K, Ozi ̧ik S., Pulmonary muscle strength, pulmonary function tests, and dyspnea in women with major depression. J Womens Health (Larchmt) 2004;13(1):93-98.
43. Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 2010;104(6): 849-857.
44. Lord SR, Menz HB. Physiologic, psychologic, and health predictors of 6-minute walk performance in older people. Arch Phys Med Re-habil 2002;83(7):907-911.
45. Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Bio-markers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011;12:3.
46. Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damas JK, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J 2010;35(3):540-548.
47. van Schayck CP. Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? Eur Respir J 2000;15(2):238-239.
48. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121(5):1434-1440.